Browser Extension

Sunday, May 25, 2025

US Edition

Israel-Hamas Conflict

Cannes Film Festival

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Microdose Psychedelic Insights image

News from Microdose Psychedelic Insights

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Memorial Day Baseball Social Media Wrestling Military

Trending in U.S.Israel-Hamas Conflict Memorial Day Baseball NCAA US Politics

Trending in U.K.Israel-Hamas Conflict Premier League Manchester United Arsenal FC Soccer

Trending Topics

Memorial Day Baseball Social Media Wrestling Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Microdose Psychedelic Insights

Your destination for news from Microdose Psychedelic Insights. See how Microdose Psychedelic Insights’s media bias impacts the breaking news stories of today.

In total, 7 have been published by Microdose Psychedelic Insights which Ground News has aggregated in the past 3 months.

Microdose Psychedelic Insights’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Microdose Psychedelic Insights’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Your destination for news from Microdose Psychedelic Insights. See how Microdose Psychedelic Insights’s media bias impacts the breaking news stories of today. In total, 7 have been published by Microdose Psychedelic Insights which Ground News has aggregated in the past 3 months.

Microdose Psychedelic Insights’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Microdose Psychedelic Insights’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Microdose Psychedelic Insights

Where is Microdose Psychedelic Insights located?Microdose Psychedelic Insights's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Microdose Psychedelic Insights News

MIT Researchers Discover New Potential Drug Targets for Alzheimer’s Disease

Alzheimer's Disease

MIT Researchers Discover New Potential Drug Targets for Alzheimer’s Disease

71% Center coverage: 7 sources

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.See the Story

Healing Beyond Addiction: New Research Shows Family Relationships Key to Lasting Recovery

Addiction · Mississippi

Healing Beyond Addiction: New Research Shows Family Relationships Key to Lasting Recovery

Addiction doesn’t just affect individuals—it ripples through entire families, leaving behind fractured relationships and emotional wounds that can last for generations. But new research is bringing hope. According to findings from the Last Resort Recovery Center, family involvement in addiction recovery can dramatically improve outcomes, increasing success rates by up to 50%. In this powerful report, Briana Sefcik, MS, LCSW, CSAT, Director of Tr…Read Article

You've scrolled to the bottom of the feed, there are no more stories.

Psilocybin use rises across all age groups following 2019 decriminalization, study finds

Psilocybin use rises across all age groups following 2019 decriminalization, study finds

Psilocybin use rises across all age groups following 2019 decriminalization, study finds

61% Center coverage: 23 sources

A multisource observational study aimed to quantify the change in prevalence and health care utilization of psilocybin users between 2014 and 2023. The study found that the prevalence of psilocybin use increased across all age groups, with those with mental or physical comorbidities among the most common users.Psychedelic Drugs · United States See the Story

No More Silence: The Opioid Epidemics Alarming Impact on Women

No More Silence: The Opioid Epidemics Alarming Impact on Women

The opioid epidemic continues to devastate communities across the country, with middle-aged women experiencing a particularly alarming rise in overdose deaths. Research from Pathways Recovery Center highlights a 260% increase in opioid-related fatalities among women aged 30-64 between 1999 and 2017. These numbers are more than just statistics—they represent the untold stories of mothers, daughters, sisters, and friends who have lost their lives …Iceland · Iceland See the Story

The Future of Psychedelics: Why Next-Generation Molecules Will Win

The Future of Psychedelics: Why Next-Generation Molecules Will Win

The psychedelic industry stands at the cusp of a transformative era, propelled by the development of next-generation molecules with the potential to be more effective treatments for a host of indications without the traditional hallucinogenic effects. Companies like Enveric Biosciences, Delix Therapeutics, and Gilgamesh Pharmaceuticals are at the forefront of this evolution, pioneering compounds that could redefine mental health treatment. The L…United States · United States Read Article

Can Enveric's Newly Patented Compounds Transform Addiction and ADHD Treatment? Patent Details Revealed

Can Enveric's Newly Patented Compounds Transform Addiction and ADHD Treatment? Patent Details Revealed

Enveric's patented mescaline derivatives show promising interaction with key brain receptors involved in opioid withdrawal, ADHD, anxiety, and depression treatment.United States · United States See the Story